Valitacell

Dublin, Ireland Founded: 2014 • Age: 12 yrs Acquired By Beckman Coulter
Provider of products to measure antibody concentration and host cell stability

About Valitacell

Valitacell is a Healthcare company based in Dublin (Ireland) founded in 2014, and was acquired by Beckman Coulter in September 2022. Provider of products to measure antibody concentration and host cell stability. Valitacell has raised $1.45 million across 9 funding rounds from investors including Beckman Coulter, European Union and EIC Fund. Its focus areas include Biopharma Outsourcing, CDMO and Biologics.

Company details

Valitacell was founded in 2014 in Dublin, Ireland, within the biotechnology sector focused on cell-based manufacturing. High-throughput assays are offered to enhance process efficiency, including the Fluoroprotein platform for IgG concentration measurement and the ChemStress platform for simulating bioreactor stresses on host cells. Predictions of cell performance during early development stages are enabled through these technologies, supporting biopharmaceutical production.

Key Metrics

Funding Insights of Valitacell

Valitacell has successfully raised a total of $1.45M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $841.42 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.45M
  • Total Rounds 9
  • Last Round Grant β€” $841,423
  • First Round $21,202

    (Jun 2016)

  • Investors Count 3

All 9 funding rounds of Valitacell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2020$841,423Grant––
Sep 2019$137,167Grant––
Jun 2019$1.27MGrant––
Mar 2019Grant––
Oct 2017$2.4MGrant––
Jun 2017$2.26MGrant––
Nov 2016$106,013Grant––
Aug 2016$1.45MSeed––
–
Jun 2016$21,202Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Valitacell

Valitacell has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Beckman Coulter, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
InterTradeIreland is focused on connecting businesses across Ireland for growth.
intertradeireland.comNewry, Ireland
Clinical diagnostic products are manufactured for biomedical testing.
1935beckmancoulter.comBrea, United States
Premium access

Investor details for Valitacell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Valitacell

4 dated milestones of Valitacell across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Valitacell is founded.
  2. Funding First funding round of $21K.
  3. Funding Latest funding round, Grant, of $841K.
  4. Exit Acquired by Beckman Coulter.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Valitacell

Premium access

Complete news archive for Valitacell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Valitacell

Valitacell was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Valitacell is headquartered in Dublin, Ireland.

Valitacell is a funded company, having raised a total of $1.45M across 9 funding rounds to date. The company's 1st funding round was a Grant of $21.2K, raised on Jun 2016.

Valitacell was founded in 2014 in Dublin, Ireland, within the biotechnology sector focused on cell-based manufacturing. High-throughput assays are offered to enhance process efficiency, including the Fluoroprotein platform for IgG concentration measurement and the ChemStress platform for simulating bioreactor stresses on host cells. Predictions of cell performance during early development stages are enabled through these technologies, supporting biopharmaceutical production.

Valitacell has 4 investors. Key investors include Beckman Coulter, European Union, EIC Fund, and InterTradeIreland.

Yes. Valitacell was acquired by Beckman Coulter in September 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available